DHS Supports the CDC Recommendation for Spring 2024 COVID-19 Vaccine for Adults Ages 65 and Older
This email is being sent to local health officers, Tribal health directors, Wisconsin vaccinators, and key DHS staff.
People ages 65 years and older should receive 1 additional dose of any updated (2023–2024 formula) COVID-19 vaccine (Moderna, Novavax, Pfizer-BioNTech) at least 4 months following the previous dose of updated (2023–2024 formula) COVID-19 vaccine.
-
For initial vaccination with Novavax COVID-19 vaccine, the 2-dose series should be completed before administration of the additional dose.
-
If Moderna is used, administer 0.5 mL/50 ug.
-
If Novavax is used, administer 0.5 mL/5 ug rS protein and 50 ug Matrix-M adjuvant.
-
If Pfizer-BioNTech is used, administer 0.3 mL/30 ug.
CDC Clinical Considerations
Immunization Policy and Procedure Manual
The Immunization Program Policy and Procedure (P&P) Manual will be updated soon. A separate email communication will be sent to local health officers and Tribal health directors when this is updated.
Staying Up to Date with Vaccines
We ask you to encourage people to stay up to date on all their recommended vaccines, including the COVID-19 vaccine.
Bridge Access Program
For adults without insurance or whose insurance does not cover COVID-19 vaccines, vaccines are available at no cost through the Bridge Access Program (BAP).
To find a BAP provider visit vaccines.gov.
Enter your zip code and the vaccine you are looking for and choose “Bridge Access Program Participant.”
|